Difference between revisions of "Neuromuscular pathology"

Jump to navigation Jump to search
(→‎Fibre types: Morphology, ATPase)
Line 189: Line 189:
===Approach===
===Approach===
General:
General:
#Size variation - in groups (neurogenic) vs. singular (myogenic).  
*Neurogenic or myopathic?
*Acute or chronic?
Check:
#Size variation - in groups (neurogenic, Dystrophinopathies) vs. singular scattered (myogenic, acute neurogenic).  
#Shape - angulated (neurogenic) vs. round (myogenic).
#Shape - angulated (neurogenic) vs. round (myogenic).
#Position of nuclei - peripheral (normal); central (myogenic; centronuclear myopathy<ref>URL: [http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html]. Accessed on: 26 October 2010.</ref>).
#Position of nuclei - peripheral (normal); central (myogenic; centronuclear myopathy<ref>URL: [http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html http://www.igbmc.fr/recherche/Dep_NG/Eq_JLaporte/JL3.html]. Accessed on: 26 October 2010.</ref>).
#[[Necrosis]] - suggests myogenic.
#[[Necrosis]] & regeneration - suggests acute myogenic.
#Fibrosis - suggests myogenic.
#Fibrosis - suggests chronic myogenic.
#Inflammation - suggest myogenic vs. systemic inflammatory.
#Inflammation - suggest myogenic vs. systemic inflammatory.
#*Lymphocytes, macrophages, eosinophils - or even neoplastic?
#Fibre type predominance - suggest congenital myopathy (esp. in small type 1 fibres), demyelinating neuropathy.
Other:
Other:
#Obvious abnormality vs. minimal change.
#Obvious abnormality vs. minimal change.
#Diffuse vs. focal change.
#Diffuse vs. focal change.
#Pathology in adjacent vessels or connective tissue.


==Processing of muscle biopsies==
==Processing of muscle biopsies==
Account-creators
1,040

edits

Navigation menu